What does JJDC invest in?
JJDC invests most often at Series A and Series B (75% of the rounds on record).
Last cheque observed Nov 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
QuietInvestment firm
12 rounds on record
Mostly Series A and Series B: 75% of its rounds
Sole investor in 2 rounds, median $36M
Every round we can evidence, newest first12 appearances
5 rounds
5 rounds
1 round
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The investors most often in the same rounds as JJDC. A count of rooms they were both in, not a relationship either has claimed.
The latest companies JJDC put money into.
JJDC invests most often at Series A and Series B (75% of the rounds on record).
12 investments on record, 0 of them in the last 12 months, and it led 2. The most recent was in Nov 2019.
Its most recent investments on record: ProteKt Therapeutics (Undisclosed round, Nov 2019), Adicet Bio (Series B, Oct 2019) and X-Vax (Series A, Jul 2019).
The median round it joins is $33M.
Yes: it led 2 of its 12 investments on record (17%).
Most of the companies it backs are in the United States (83%), Israel (8%) and Germany (8%).
No investments in the last 12 months; the latest was in Nov 2019.
Most often Alexandria Real Estate Equities (2 rounds together) and Hatteras Venture Partners (2 rounds together).
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it